Global Apolipoprotein Testing Market Report to 2029 – With ACM Medical Lab, Spectra Laboratories and Quest Diagnostics, among others –


DUBLIN–(BUSINESS WIRE)–The “Apolipoprotein Testing Market Report by Indication, End-Users and Region – Global Forecast to 2029” report has been added to from offer.

The apolipoprotein testing market size is estimated at USD 19.21 billion in 2021 and is expected to witness a CAGR of 9.35% during the forecast period 2022-2029.

Companies cited

  • ACM Medical Laboratory (USA)

  • Eurofins Scientific (Luxembourg)

  • Clinical Reference Laboratory Inc. (CRL) (USA)

  • Spectra Laboratories Inc. (USA)

  • Holdings (LabCorp) (USA)

  • Unilabs (Switzerland)

  • SYNLAB International GmbH (Germany)

  • Bio-Reference Laboratories Inc. (USA)

  • Quest Diagnostics Incorporated (USA)

  • Adicon Clinical Laboratory (China)

Rising health awareness regarding various heart issues, changes in dietary and lifestyle habits, and growing geriatric population are expected to drive the market growth in the near future. However, the lack of knowledge about cardiovascular health related issues is expected to restrain the market growth.

By indication

Based on indications, the market is categorized into obesity, hypertension, cardiovascular disorders, and others. In 2021, cardiovascular disorders accounted for the highest revenue share due to increasing cases of cardiovascular disorders and rising prevalence of obesity and hypertension.

Per end user

On the basis of end-user, the market is categorized into diagnostic laboratories, ambulatory surgery centers, hospitals, clinical laboratories. In the global market, the hospital segment accounted for the largest share of revenue in 2021 owing to the increase in the population of hospitals and laboratories.

Regional markets in 2021

North America accounted for the highest revenue in the apolipoprotein testing market and is expected to maintain its dominance over the forecast period. This is attributed to the region’s advanced healthcare systems, expanding population, and increasingly health-conscious people.

This comprehensive research report focuses on the global and regional market size and forecast of various segments including indication and end user from 2021 to 2029.

Segmentation: Apolipoprotein Testing Market Report 2021-2029 by Indication (Revenue, Billion USD)

  • Obesity

  • Hypertension

  • Cardiovascular disorders

  • Others

Per End User (Revenue, Billion USD)

  • Diagnostic laboratories

  • Ambulatory surgery centers

  • Hospitals

  • Clinical laboratories

By region (revenue, billion USD)

North America


  • Germany

  • France

  • UK

  • Spain

  • Italy

  • The rest of Europe

Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of APAC

Latin America

  • Brazil

  • Mexico

  • Argentina

  • Rest of LATAM

Middle East and Africa

  • South Africa

  • GCC

  • Rest of MEA

For more information on this report, visit


Comments are closed.